High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone

We tested the feasibility and toxicity of high activities Rhenium-186 hydroxyethylidene diphosphonate, with peripheral blood stem cell rescue in patients with progressive hormone refractory prostate cancer metastatic to bone. Twenty-five patients received between 2500 and 5000 MBq of Rhenium-186 hyd...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Sullivan, J M, McCready, V R, Flux, G, Norman, A R, Buffa, F M, Chittenden, S, Guy, M, Pomeroy, K, Cook, G, Gadd, J, Treleaven, J, Al-Deen, A, Horwich, A, Huddart, R A, Dearnaley, D P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375418/
https://www.ncbi.nlm.nih.gov/pubmed/12087455
http://dx.doi.org/10.1038/sj.bjc.6600348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375418/
https://www.ncbi.nlm.nih.gov/pubmed/12087455
http://dx.doi.org/10.1038/sj.bjc.6600348

Ejemplares similares